Biocon surges on receiving EIR from USFDA for API manufacturing facility in Bengaluru

08 May 2020 Evaluate
Biocon is currently trading at Rs. 356.05, up by 6.40 points or 1.83% from its previous closing of Rs. 349.65 on the BSE.

The scrip opened at Rs. 356.00 and has touched a high and low of Rs. 357.45 and Rs. 349.50 respectively. So far 59194 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 367.80 on 20-Apr-2020 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 367.00 and Rs. 345.35 respectively. The current market cap of the company is Rs. 42834.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.64% and 17.70% respectively.

Biocon has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the Pre-Approval and GMP inspection of its Small Molecules API Manufacturing Facility at Biocon Park SEZ, Bommansandra, Bengaluru, conducted between January 20 and January 24, 2020.

At the conclusion of the inspection the agency had issued a Form 483, with five observations, which are being addressed by the Company. The EIR has been closed with a ‘VAI’ classification for the observations.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.15 5.75 (1.49%)
18-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.00
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 910.00
Lupin 2119.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×